Why Novo underestimated demand

Since Novo Nordisk launched Wegovy in 2021, it has dominated the fast-growing market for slimming drugs. Now a new jab is eating into the Danish firm’s success. Why a slang expert thinks the first word humans ever uttered may have been a profane one. And why British sheep have got happier. 

Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+

For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. 

Hosted on Acast. See acast.com/privacy for more information.